Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Tanning bed use is associated with the development of skin cancers. Now a new study looks at how many skin cancers and associated healthcare costs would be impacted if teenagers were prohibited from using tanning beds. William Nelson, director of …
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Imagine you have moderate to severe depression. Would you stop taking your medicines to be part of a research study comparing psilocybin to a traditional antidepressant? That was a requirement for participants in a recently reported study, and Matthew Johnson, …
Podcast: Download (Duration: 1:01 — 1.4MB)
Subscribe: RSS
Psilocybin compared favorably with a traditional antidepressant for treating moderate to severe depression, a recent study found. Matthew Johnson, a psychedelics researcher at Johns Hopkins, says an entirely different clinical approach will be required to use psilocybin routinely for depression. …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
For people with depression, sometimes traditional antidepressant medicines simply don’t work. Now psychedelic medicines may be a new choice, if the results of a study comparing psilocybin to escitalopram, an antidepressant, hold up. Matthew Johnson, a psychedelics researcher at Johns …
Could psychedelic medicines replace antidepressants? Elizabeth Tracey reports Read more »
Podcast: Download (Duration: 1:03 — 1.4MB)
Subscribe: RSS
Depression can be hard to treat, with even established medicines taking time to be effective and perhaps not helping at all. Now a new study compared the psychedelic drug psilocybin with escitalopram, an established antidepressant, and the results impressed Matthew …
Podcast: Download (Duration: 1:03 — 1.5MB)
Subscribe: RSS
Can the psychedelic drug psilocybin be used to treat depression? That possibility was examined in a recent study comparing psilocybin to escitalopram, an established antidepressant, in people with moderate to severe depression. Matthew Johnson, a psychedelics researcher at Johns Hopkins, …
